John Bishop, based in Biddeford, Maine, United States, is currently a Chief Technology Officer at Lyra Therapeutics, bringing experience from previous roles at Novo Nordisk, Forma Therapeutics, Epizyme and Genocea. John Bishop holds a 1983 - 1988 Doctor of Philosophy (Ph.D.) in Organic Chemistry @ University of California, Berkeley. With a robust skill set that includes Drug Discovery, GMP, Leadership, Technology Transfer, Drug Development and more, John Bishop contributes valuable insights to the industry. John Bishop has 3 emails and 1 mobile phone number on RocketReach.